head uk2

Clinical Studies

Clinical trials are the basis for the development and marketing of new drugs and medical devices. When studying new chitosan-based medical devices, the necessity of a clinical trial depends on the Class of the medical device and the country of registration (EU/US market). In a clinical trial, participants receive specific interventions according to a research protocol to demonstrate the safety and effectiveness of the device compared to a control (placebo or current standard). Drug studies are performed in phase I to phase IV, while medical device studies are classified as pilot, pivotal and post-approval study. Find out more about currently registered clinical trials with chitosan-based products and outcomes of completed trials in the following articles.

Display #
Title Created Date Hits
Respirators with chitosan nanoparticles as protection against SARS-CoV-2 infection 16 December 2020 1869
Recent and ongoing clinical studies with chitosan 23 March 2020 1884
Clinical Studies with Chitosan 12 March 2018 4639
Efficiency of Chitosan in toothpaste 29 November 2010 6751

Congress and fairs

Meet us in person 2022:

  • EUCHIS, 2022
  • CPHI 2022
  • Medica 2022
  • Asia Pacific Chitin and Chitosan Symposium, 2022, South Korea

To arrange an appointment please contact Katja Richter via sales(at)


  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.